• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

ReCor Medical

Court revives renal denervation patent battle between ReCor, Medtronic

April 3, 2025 By Sean Whooley

A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office (USPTO), reviving a spat between Recor Medical and Medtronic. The patent battle centers around renal denervation (RDN) technology for treating hypertension. Recor and Medtronic are the two leaders in this space, with Recor Medical receiving an FDA nod for its Paradise […]

Filed Under: Cardiovascular, Catheters, Featured, Legal News, Neurological, Patent Infringement, Ultrasound Tagged With: Medtronic, ReCor Medical

Medtronic achieves renal denervation reimbursement milestone with CMS

January 14, 2025 By Sean Whooley

Medtronic announced that CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension. This process allows the agency to review and develop a national Medicare coverage policy for RDN procedures. CMS initiated the analysis after Medtronic requested beneficiary access support for its Symplicity Spyral RDN system. A national coverage […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Medicare, Vascular Tagged With: Medtronic, ReCor Medical

Medtronic, Recor Medical score renal denervation reimbursement wins

November 5, 2024 By Danielle Kirsh

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies. Going into effect on Jan. 1, 2025, the approvals could increase patient access to the new hypertension treatments. Medtronic secured a Transitional Pass-Through (TPT) payment under the Medicare Hospital Outpatient Prospective Payment System for its Symplicity Spyral renal […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic, ReCor Medical, Reimbursement, renal denervation

Medtronic, Recor Medical applaud European support for renal denervation

August 31, 2024 By Sean Whooley

Medtronic praised new European Society of Cardiology (ESC) 2024 guidelines for renal denervation (RDN) procedures for hypertension. The ESC upgraded renal denervation to a Class IIb recommendation for patients with uncontrolled and resistant hypertension. Officials presented the new guidelines at the ESC Congress on Aug. 30 in London. Medtronic said the new guidelines outline patient […]

Filed Under: Cardiovascular, Catheters, Featured, Vascular Tagged With: Medtronic, ReCor Medical

Medtronic, Recor Medical earn CMS NTAP wins for renal denervation tech

August 12, 2024 By Sean Whooley

Medtronic and Recor Medical earned a reimbursement win for their renal denervation (RDN) platforms with a new Final Rule from CMS. CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which includes the New Technology Add-on Payment (NTAP) program. NTAP supports access for newly approved, innovative technologies where the cost to adopt may […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Medicare, Vascular Tagged With: ambulatory surgery centers (ASCs), Centers for Medicare and Medicaid Services (CMS), Medtronic, ReCor Medical

The top medtech trends of 2023

December 20, 2023 By Chris Newmarker

The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Cardiovascular, Catheters, Diabetes, Dialysis, Featured, Health Technology, In-Depth Coverage, Mergers & Acquisitions, News Well, Orthopedics, Pulsed-Field Ablation (PFA), Recalls, Respiratory, Robotic-Assisted, Software / IT, Special Content, Surgical Robotics Tagged With: 3M Health Care, Abbott, Ablative Solutions, Avail Medsystems, Biosense Webster, Boston Scientific, Dexcom, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, Mozarc Medical, Philips, Philips Respironics, ReCor Medical, renal denervation, Solventum, Stryker, Titan Medical, Zimmer Biomet

What’s next for Medtronic’s RDN program after FDA approval?

November 27, 2023 By Jim Hammerand

Medtronic is planning its first commercial renal denervation (RDN) cases and is already running a postmarket study after winning FDA approval of its Symplicity Spyral system for hypertension. In an interview before the Thanksgiving break, Medtronic SVP Jason Weidman — who’s also president of the company’s coronary and RDN business — said he expects the […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Contract Manufacturing, Featured, Food & Drug Administration (FDA), In-Depth Coverage, News Well, Outsourcing, Special Content Tagged With: FDA, Medtronic, RDN, ReCor Medical, renal denervation

Recor Medical launches renal denervation system, announces first commercial cases

November 13, 2023 By Sean Whooley

Recor Medical announced the first commercial uses of its Paradise ultrasound renal denervation (uRDN) system for treating hypertension. The first commercial uses follow the company’s landmark FDA approval for Paradise last week. Approval allows for the use of Paradise as an adjunctive treatment option when lifestyle changes and medications fail to control a patient’s blood […]

Filed Under: Business/Financial News, Cardiovascular, Featured, News Well Tagged With: ReCor Medical, renal denervation

Recor Medical wins first FDA nod for renal denervation to treat hypertension

November 8, 2023 By Sean Whooley

Recor Medical announced that the FDA approved its Paradise ultrasound renal denervation (RDN) system for treating hypertension. The long-awaited approval for the Otsuka Medical Devices portfolio company allows for the use of Paradise as an adjunctive treatment option when lifestyle changes and medications fail to adequately control a patient’s blood pressure. Paradise had looked the […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: ReCor Medical, renal denervation

Recor Medical presents more data supporting its renal denervation system

October 27, 2023 By Sean Whooley

Otsuka Medical Devices’ Recor Medical announced another set of positive study results for its Paradise ultrasound renal denervation (uRDN) system. A combined analysis of six-month follow-up data from three RADIANCE global studies evaluated Paradise as a hypertension treatment. The analysis demonstrated maintained blood pressure (BP) reduction following treatment with uRDN compared to sham. It also […]

Filed Under: Cardiovascular, Clinical Trials, Featured, News Well Tagged With: ReCor Medical, renal denervation, TCT 2023

The biggest cardiovascular stories from TCT 2023

October 26, 2023 By Sean Whooley

Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Drug-Eluting Stents, Featured, Implants, In-Depth Coverage, News Well, Replacement Heart Valves, Special Content, Stents, Structural Heart Tagged With: Abbott, Avertix Medical, Boston Scientific, Conformal Medical, Edwards Lifesciences, GE Healthcare, JenaValve, Medtronic, ReCor Medical, tavr, TCT 2023

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy